newsfilter
← Latest News
GlobeNewswire·

IGM Biosciences to Present at the Morgan Stanley 21st Annual Global Healthcare Conference

MOUNTAIN VIEW, Calif., Sept. 06, 2023 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (NASDAQ:IGMS), a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies, today announced that